Cell Membrane Biomimetic Nanoparticles with Potential in Treatment of Alzheimer’s Disease

Alzheimer’s disease (AD) is to blame for about 60% of dementia cases worldwide. The blood–brain barrier (BBB) prevents many medications for AD from having clinical therapeutic effects that can be used to treat the affected area. Many researchers have turned their attention to cell membrane biomimeti...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhong, Xinyu, Na, Yue, Yin, Shun, Yan, Chang, Gu, Jinlian, Zhang, Ning, Geng, Fang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005336/
https://www.ncbi.nlm.nih.gov/pubmed/36903581
http://dx.doi.org/10.3390/molecules28052336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10005336/
https://www.ncbi.nlm.nih.gov/pubmed/36903581
http://dx.doi.org/10.3390/molecules28052336

Ejemplares similares